Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Chan

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|April 3, 2023
Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and VoriconazoleVictoria G Hall, Kenny Tang, Deepali Kumar, et al.
Blood|May 23, 2014
Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cellsLe Xuan Truong Nguyen, Steven M Chan, Tri Duc Ngo, et al.
Nature Communications|March 11, 2025
TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signalingYitong Yang, Severine Cathelin, Alex C H Liu, et al.
Oncotarget|October 13, 2016
Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cellsMin Huang, Jacqueline S Garcia, Daniel Thomas, et al.
Cancer Research|September 23, 2022
Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of StemnessAlex C H Liu, Severine Cathelin, Yitong Yang, et al.
Nature Medicine|January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemiaSteven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Blood Cancer Journal|November 1, 2024
Genomic profiles and outcomes in de novo versus therapy-related core binding factor AMLMay Chiu, Aaron D Schimmer, Andre C Schuh, et al.
Science Translational Medicine|November 1, 2019
Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress responseDavid Sharon, Severine Cathelin, Sara Mirali, et al.
Blood|November 16, 2014
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibitionSubarna Sinha, Daniel Thomas, Linda Yu, et al.
Ejhaem|February 23, 2023
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimenIbrahim Al Nabhani, Claire Andrews, Jad Sibai, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|April 3, 2023
Breakthrough Invasive Fungal Infection After Coadministration of Venetoclax and VoriconazoleVictoria G Hall, Kenny Tang, Deepali Kumar, et al.
Blood|May 23, 2014
Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cellsLe Xuan Truong Nguyen, Steven M Chan, Tri Duc Ngo, et al.
Nature Communications|March 11, 2025
TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signalingYitong Yang, Severine Cathelin, Alex C H Liu, et al.
Oncotarget|October 13, 2016
Autophagy mediates proteolysis of NPM1 and HEXIM1 and sensitivity to BET inhibition in AML cellsMin Huang, Jacqueline S Garcia, Daniel Thomas, et al.
Cancer Research|September 23, 2022
Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of StemnessAlex C H Liu, Severine Cathelin, Yitong Yang, et al.
Nature Medicine|January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemiaSteven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Blood Cancer Journal|November 1, 2024
Genomic profiles and outcomes in de novo versus therapy-related core binding factor AMLMay Chiu, Aaron D Schimmer, Andre C Schuh, et al.
Science Translational Medicine|November 1, 2019
Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress responseDavid Sharon, Severine Cathelin, Sara Mirali, et al.
Blood|November 16, 2014
Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibitionSubarna Sinha, Daniel Thomas, Linda Yu, et al.
Ejhaem|February 23, 2023
Safety of re-challenging adults with acute lymphoblastic leukemia with PEG-asparaginase-induced severe hypertriglyceridemia when treated with a pediatric-inspired regimenIbrahim Al Nabhani, Claire Andrews, Jad Sibai, et al.
Pageof 7